Fenlean
Fenlean (FLZ) is a synthetic Src kinase inhibitor derived from Annona glabra. It demonstrates cytoprotective effects in a chronic MPTP mouse model of Parkinson's disease by preserving tyrosine hydroxylase function and inhibiting mitochondrial Aβ production, supporting research in neurodegeneration and age-related macular degeneration.
Product Specifications
CAS Number
863193-70-8
Product Name Alternative
β Amyloid, βAmyloid, Src, BetaAmyloid, Beta Amyloid, bAmyloid, b Amyloid, Aβ, FLZ, Fenlean
Field of Research
Cardiovascular Research, Neuroscience, Signal Transduction
Purity
98.99% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (7.34 mM) ; DMSO:80 mg/mL (177.98 mM)
Smiles
O=C (NCCC1=CC=C (O) C=C1) C (=CC2=CC=C (O) C (OC) =C2) C3=CC (OC) =CC=C3OC
Molecular Formula
C26H27NO6
Molecular Weight
449.5
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Explore Other Products
Browse additional items from our catalog
Glycogen Synthase Kinase 3 alpha, phosphorylated (Ser21) (GSK3a)